Rx (Prescription Medicine)
USD $ 600.00
Bdparib 300mg Tablet 是一种靶向治疗药物。其活性成分是一种PARP抑制剂，专门用于干扰癌细胞中受损DNA的修复。尤其是具有特定基因突变（如BRCA）的癌细胞，对PARP的依赖性比正常细胞更强。通过抑制PARP，Bdparib 阻止这些癌细胞修复DNA，从而导致细胞死亡。该机制在治疗某些类型的卵巢癌、输卵管癌和主发性腹膜癌方面尤为有效，特别是在之前对铂类化疗有反应的患者中。典型剂量为 300mg 每日两次，但应始终按照医疗专业人员的处方服用。常见的不良反应可能包括恶心、疲劳、呕吐、头痛和腹泻。应将 Bdparib 300mg Tablets 存放于室温，远离潮湿和热源，并置于儿童不易触及的地方。
| Molecule | |
|---|---|
| Strength | |
| Pack Quantity | |
| Medicine Form | |
| Medicine Type | |
| Rx Status | |
| Country Of Origin | |
| Packaging Type | |
| Brand Name |
未库存此 exact 强度的其他品牌，因此这些是其他强度的 Olaparib. 未经开方医生建议，请勿更改剂量。
医学审核
Renu Meena, B.Pharm
Medical Content Writer
Renu Meena is an experienced Medical Content Writer with a strong foundation in pharmacy practice. She holds a Bachelor of Pharmacy (B.Pharm) degree from Rajasthan University of Health Sciences (RUHS), Jaipur, and is registered with the Rajasthan State Pharmacy Council (Reg. No. 55661). With 4+ years of experience across clinical pharmacy and medical content development, she creates evidence-based content for medicines, diseases, and patient education. Her work is shaped by a strong understanding of pharmacovigilance and regulatory standards, including ICH guidelines, GVP modules, ICD-10/11, and safety reporting requirements. Renu focuses on making complex medical information simple, accurate, and useful for readers while maintaining high quality and compliance.
